| Scientific Name |
Valproate Sodium
|
|---|---|
| Brand Name |
Depakine
|
| Risk |
Risk of abnormal pregnancy outcomes, New measures regarding the potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the 3 months prior to conception.
|
| Educational Materials for Healthcare Professionals |
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|
| Educational Materials for Patients |
|